www.fdanews.com/articles/183559-fda-approves-two-ortho-hepatitis-b-assays
FDA Approves Two Ortho Hepatitis B Assays
September 18, 2017
Ortho Clinical Diagnostics received FDA approval for its Vitros HBeAg and Anti-HBe assays for use with the company’s Vitros 5600 and 3600 systems.
Both assays are currently available on the Vitros ECi/ECiQ immunodiagnostic systems.
The assays are used to diagnose individuals with acute or chronic hepatitis B or in recovery from hepatitis B infection.